Cargando…

Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life‐threatening, yet noninvasively differentiating NASH from simple steatosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Anurag, Castañeda, Tamara R., Bader, Erik, Elshorst, Bettina, Cummings, Sheila, Scherer, Petra, Bangari, Dinesh S., Loewe, Claudia, Schreuder, Herman, Pöverlein, Christoph, Helms, Mike, Jones, Seth, Zech, Gernot, Licher, Thomas, Wagner, Michael, Schudok, Manfred, de Hoop, Meltsje, Plowright, Alleyn T., Atzrodt, Jens, Kannt, Aimo, Laitinen, Iina, Derdau, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739951/
https://www.ncbi.nlm.nih.gov/pubmed/33344141
http://dx.doi.org/10.1002/advs.202002997
_version_ 1783623425787428864
author Mishra, Anurag
Castañeda, Tamara R.
Bader, Erik
Elshorst, Bettina
Cummings, Sheila
Scherer, Petra
Bangari, Dinesh S.
Loewe, Claudia
Schreuder, Herman
Pöverlein, Christoph
Helms, Mike
Jones, Seth
Zech, Gernot
Licher, Thomas
Wagner, Michael
Schudok, Manfred
de Hoop, Meltsje
Plowright, Alleyn T.
Atzrodt, Jens
Kannt, Aimo
Laitinen, Iina
Derdau, Volker
author_facet Mishra, Anurag
Castañeda, Tamara R.
Bader, Erik
Elshorst, Bettina
Cummings, Sheila
Scherer, Petra
Bangari, Dinesh S.
Loewe, Claudia
Schreuder, Herman
Pöverlein, Christoph
Helms, Mike
Jones, Seth
Zech, Gernot
Licher, Thomas
Wagner, Michael
Schudok, Manfred
de Hoop, Meltsje
Plowright, Alleyn T.
Atzrodt, Jens
Kannt, Aimo
Laitinen, Iina
Derdau, Volker
author_sort Mishra, Anurag
collection PubMed
description Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life‐threatening, yet noninvasively differentiating NASH from simple steatosis is challenging. Herein, bifunctional probes have been developed that target the hepatocyte‐specific asialoglycoprotein receptor (ASGPR), the expression of which decreases during NASH progression. The results show that the probes allow longitudinal, noninvasive monitoring of ASGPR levels by positron emission tomography in the newly developed rat model of NASH. The probes open new possibilities for research into early diagnosis of NASH and development of drugs to slow or reverse its progression.
format Online
Article
Text
id pubmed-7739951
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77399512020-12-18 Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis Mishra, Anurag Castañeda, Tamara R. Bader, Erik Elshorst, Bettina Cummings, Sheila Scherer, Petra Bangari, Dinesh S. Loewe, Claudia Schreuder, Herman Pöverlein, Christoph Helms, Mike Jones, Seth Zech, Gernot Licher, Thomas Wagner, Michael Schudok, Manfred de Hoop, Meltsje Plowright, Alleyn T. Atzrodt, Jens Kannt, Aimo Laitinen, Iina Derdau, Volker Adv Sci (Weinh) Full Papers Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease that can lead to irreversible liver cirrhosis and cancer. Early diagnosis of NASH is vital to detect disease before it becomes life‐threatening, yet noninvasively differentiating NASH from simple steatosis is challenging. Herein, bifunctional probes have been developed that target the hepatocyte‐specific asialoglycoprotein receptor (ASGPR), the expression of which decreases during NASH progression. The results show that the probes allow longitudinal, noninvasive monitoring of ASGPR levels by positron emission tomography in the newly developed rat model of NASH. The probes open new possibilities for research into early diagnosis of NASH and development of drugs to slow or reverse its progression. John Wiley and Sons Inc. 2020-11-09 /pmc/articles/PMC7739951/ /pubmed/33344141 http://dx.doi.org/10.1002/advs.202002997 Text en © 2020 The Authors. Published by Wiley‐VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Papers
Mishra, Anurag
Castañeda, Tamara R.
Bader, Erik
Elshorst, Bettina
Cummings, Sheila
Scherer, Petra
Bangari, Dinesh S.
Loewe, Claudia
Schreuder, Herman
Pöverlein, Christoph
Helms, Mike
Jones, Seth
Zech, Gernot
Licher, Thomas
Wagner, Michael
Schudok, Manfred
de Hoop, Meltsje
Plowright, Alleyn T.
Atzrodt, Jens
Kannt, Aimo
Laitinen, Iina
Derdau, Volker
Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title_full Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title_fullStr Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title_full_unstemmed Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title_short Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
title_sort triantennary galnac molecular imaging probes for monitoring hepatocyte function in a rat model of nonalcoholic steatohepatitis
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739951/
https://www.ncbi.nlm.nih.gov/pubmed/33344141
http://dx.doi.org/10.1002/advs.202002997
work_keys_str_mv AT mishraanurag triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT castanedatamarar triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT badererik triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT elshorstbettina triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT cummingssheila triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT schererpetra triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT bangaridineshs triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT loeweclaudia triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT schreuderherman triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT poverleinchristoph triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT helmsmike triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT jonesseth triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT zechgernot triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT licherthomas triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT wagnermichael triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT schudokmanfred triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT dehoopmeltsje triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT plowrightalleynt triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT atzrodtjens triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT kanntaimo triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT laitineniina triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis
AT derdauvolker triantennarygalnacmolecularimagingprobesformonitoringhepatocytefunctioninaratmodelofnonalcoholicsteatohepatitis